Hangzhou Diagens Biotechnology Co., Ltd. (HKG:2526)
Hong Kong · Delayed Price · Currency is HKD
298.80
-31.20 (-9.45%)
At close: May 11, 2026
HKG:2526 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
|---|
| -67.14 | -43.38 | -56.12 |
Depreciation & Amortization | 10.9 | 13.63 | 7.51 |
| 0.12 | - | - |
Loss (Gain) From Sale of Assets | -2.2 | -0.18 | 0.08 |
Loss (Gain) From Sale of Investments | 9.57 | 2.07 | 1.01 |
Loss (Gain) on Equity Investments | -0.03 | 0.1 | 0 |
| 0.06 | 0.1 | 6.44 |
Other Operating Activities | 0.3 | 19.2 | 14.85 |
Change in Accounts Receivable | -28.52 | -28.09 | -1.02 |
| -0.51 | 4.2 | -2.44 |
Change in Accounts Payable | 15.08 | 4.19 | -0.28 |
Change in Other Net Operating Assets | 11.83 | -1.61 | -17.43 |
| -50.54 | -29.78 | -47.4 |
| -7.47 | -24.2 | -24.22 |
Sale of Property, Plant & Equipment | - | 0.24 | - |
| -0.11 | - | - |
Sale (Purchase) of Intangibles | -0.16 | -1.05 | - |
| 9.84 | 23.66 | -92.84 |
Other Investing Activities | - | 21 | - |
| 2.1 | 19.66 | -117.06 |
| - | 10 | - |
| - | 10 | - |
| -10 | - | - |
| -1.83 | -2.73 | -2.2 |
| -11.83 | -2.73 | -2.2 |
| -11.83 | 7.28 | -2.2 |
| 60 | - | 170.15 |
Other Financing Activities | -3.97 | -0.47 | -3.97 |
| 44.2 | 6.81 | 163.98 |
| -4.23 | -3.32 | -0.47 |
| -58 | -53.98 | -71.61 |
| -35.28% | -76.72% | -135.52% |
| -0.72 | -0.68 | -0.94 |
| 0.55 | 0.47 | 0.26 |
| - | 0.03 | - |
| -49.35 | -63.77 | - |
| -48.99 | -50.52 | - |
Change in Working Capital | -2.12 | -21.31 | -21.17 |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.